Mumps virus

Clinical Neurovirology

Volumn , Issue , 2003, Pages 431-445

  Rubin, Steven A ^a   Carbone, Kathryn M ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903999202     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (109)

1. Hamilton, R. An account of a distemper by the common people of England vulgarly called the mumps. London Med J. 1790, 11, 190–211.
2. Bang, H.O.; Bang, J. Involvement of the central nervous system in mumps. Acta Med Scand. 1943, 113, 487–505.
3. Centers for Disease Control and Prevention. Summary of Notifiable Diseases, United States, 1998. MMWR. 1999, 47, 2–92.
4. Lamb, R.A.; Kolakofsky, D. Paramyxoviridae: the viruses and their replication. In Fields Virology; Fields, B.N., Ed.; Lippincott-Raven: Philadelphia, 1996, 1177–1204.
5. Elango, N.; Varsanyi, T.M.; Kovamees, J.; Norrby, E. Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J Gen Virol. 1988, 69, 2893–2900.
6. Elliott, G.D.; Yeo, R.P.; Afzal, M.A.; Simpson, E.J.; Curran, J.A.; Rima, B.K. Strain-variable editing during transcription of the P gene of mumps virus may lead to the generation of nonstructural proteins NS1 (V) and NS2. J Gen Virol. 1990, 71, 1555–1560.
7. Paterson, R.G.; Lamb, R.A. RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J Virol. 1990, 64, 4137–4145.
8. Carbone, K.M.; Wolinsky, J.S. Mumps virus. In Fields Virology; Knipe, D.M., Howley, P.M., Eds.; Lippincott-Raven: Philadelphia, 2001, 1381–1400.
9. Orvell, C. Structural polypeptides of mumps virus. J Gen Virol. 1978, 41, 527–539.
10. McCarthy, M.; Johnson, R.T. A comparison of the structural polypeptides of five strains of mumps virus. J Gen Virol. 1980, 46, 15–27.
11. Okazaki, K.; Tanabayashi, K.; Takeuchi, K.; Hishiyama, M.; Yamada, A. Molecular cloning and sequence analysis of the mumps virus gene encoding the L protein and the trailer sequence. Virology. 1992, 188, 926–930.
12. Matsumoto, T. Assembly of paramyxoviruses. Microbiol Immunol. 1982, 26, 285–320.
13. Orvell, C. Immunological properties of purified mumps virus glycoproteins. J Gen Virol. 1978, 41, 517–526.
14. Jensik, S.C.; Silver, S. Polypeptides of mumps virus. J Virol. 1976, 17, 363–373.
15. Merz, D.C.; Server, A.C.; Waxham, M.N.; Wolinsky, J.S. Biosynthesis of mumps virus F glycoprotein: non-fusing strains efficiently cleave the F glycoprotein precursor. J Gen Virol. 1983, 64, 1457–1467.
16. Naruse, H.; Nagai, Y.; Yoshida, T.; Hamaguchi, M.; Matsumoto, T.; Isomura, S.; Suzuki, S. The polypeptides of mumps virus and their synthesis in infected chick embryo cells. Virology. 1981, 112, 119–130.
17. Elango, N.; Varsanyi, T.M.; Kovamees, J.; Norrby, E. The mumps virus fusion protein mRNA sequence and homology among the paramyxoviridae proteins. J Gen Virol. 1989, 70, 801–807.
18. Houard, S.; Varsanyi, T.M.; Milican, F.; Norrby, E.; Bollen, A. Protection of hamsters against mumps virus (MuV) infection by antibodies raised against the MuV surface glycoproteins expressed from recombinant vaccinia virus vectors. J Gen Virol. 1995, 76, 421–423.
19. Takeuchi, K.; Tanabayashi, K.; Hishiyama, M.; Yamada, A. The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology. 1996, 225, 156–162.
20. Curran, J.; Marq, J.B.; Kolakofsky, D. The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology. 1992, 189, 647–656.
21. Horikami, S.M.; Hector, R.E.; Smallwood, S.; Moyer, S.A. The Sendai virus C protein binds the L polymerase protein to inhibit viral RNA synthesis. Virology. 1997, 235, 261–270.
22. Tanabayashi, K.; Takeuchi, K.; Okazaki, K.; Hishiyama, M.; Yamada, A. Expression of mumps virus glycoproteins in mammalian cells from cloned cDNAs: both F and HN proteins are required for cell fusion. Virology. 1992, 187, 801–804.
23. Lamb, R.A. Paramyxovirus fusion: a hypothesis for changes. Virology. 1993, 197, 1–11.
24. Kingsbury, D.W.; Hsu, C.H.; Murti, K.G. Intracellular metabolism of Sendai virus nucleocapside. Virology. 1978, 91, 86–94.
25. Blumberg, B.M.; Kolakofsky, D. Intracellular vesicular stomatitis virus leader RNAs are found in nucleocapsid structures. J Virol. 1981, 40, 568–576.
26. Centers for Disease Control and Prevention. Mumps surveillance 1973. MMWR. 1974, 23, 431.
27. Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1991. MMWR. 1991, 40, 3.
28. Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1996. MMWR. 1996, 45, 1–88.
29. Holmes, S.J.; Sirotkin, B.I.; Williams, W.W.; Cochi, S.L.; Hadler, S.C.; Lindegren, M.L. Mumps surveillance—United States, 1988–1993. MMWR. 1995, 44, 1–14.
30. Centers for Disease Control and Prevention. Mumps—United States, 1984–1985. MMWR. 1986, 35, 216–219.
31. Mortimore, P.P. Mumps prophylaxis in the light of a new test for antibody. Br Med J. 1978, 2, 1523–1524.
32. Weibel, R.E.; Buynak, E.B.; Whitman, J.E.; Leagus, M.B.; Stokes, J.; Hilleman, M.R. Jeryl Lynn strain live mumps virus vaccine. JAMA. 1969, 207, 1667–1670.
33. Okuno, Y.; Asada, T.; Yamanishi, K.; Otsuka, T.; Takahashi, M.; Tanioka, T.; Aoyama, H.; Fukui, O.; Matsumoto, K.; Uemura, F.; Wada, A. Studies on the use of mumps virus for treatment of human cancer. Biken J. 1978, 21, 37–49.
34. Gut, J.P.; Lablache, C.; Behr, S.; Kirn, A. Symptomatic mumps virus reinfections. J Med Virol. 1995, 45, 17–23.
35. Nojd, J.; Tecle, T.; Samuelsson, A.; Orvell, C. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine. 2001, 19, 1727–1731.
36. Centers for Disease Control and Prevention. Mumps—United States. MMWR. 1978, 27, 379–381.
37. Koskiniemi, M.; Donner, M.; Pettay, O. Clinical appearance and outcome in mumps encephalitis in children. Acta Paediatr Scand. 1983, 72, 603–609.
38. Leboreiro, A. Leboreiro-Fernandez, M. Moura-Ribeiro, I; Sawan, F.; Ventura, A.; Barbosa, K. Mumps meningoencephalitis, an epidemiological approach. Arq Neuropsiquiatr. 1997, 55, 12–15.
39. Centers for Disease Control and Prevention. Mumps surveillance report. MMWR. 1972, 21, 1–12.
40. Hope-Simpson, R.E. Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet. 1952, 2, 549–554.
41. Fleischer, B.; Kreth, H.W. Mumps virus replication in human lymphoid cell lines and in peripheral blood lymphocytes: preference for T cells. Infect Immun. 1982, 35, 25–31.
42. Wolinsky, J.S.; Klassen, T.; Baringer, J.R. Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation. J Infect Dis. 1976, 133, 260–267.
43. Ukkonen, P.; Granstrom, M.L.; Penttinen, K. Mumps-specific immunoglobulin M and G antibodies in natural mumps infection as measured by enzyme-linked immunosorbent assay. J Med Virol. 1981, 8, 131–142.
44. Wolinsky, J.S.; Baringer, J.R.; Margolis, G.; Kilham, L. Ultrastructure of mumps virus replication in newborn hamster central nervous system. Lab Invest. 1974, 31, 403–412.
45. Levitt, L.P.; Mahoney, D.H.; Casey, H.L.; Bond, J.O. Mumps in a general population: a seroepidemiologic study. Am J Dis Child. 1970, 120, 134–138.
46. Maris, E.P.; Enders, J.F.; Stokes, J.; Kane, L.W. Immunity in mumps: IV. The correlation of the presence. J Exp Med. 1946, 84, 323–339.
47. Philip, R.N.; Reinhard, K.P.; Lachman, D.B. Observations on amumps epidemic in a “virgin” population. Am J Hyg. 1959, 69, 91–111.
48. Travis, L.W.; Hecht, D.W. Acute and chronic inflammatory diseases of the salivary glands, diagnosis and management. Otolarying Clin North Am. 1977, 10, 329–338.
49. Candel, S. Epididymitis in mumps, including orchitis: further clinical studies and comment. Ann Intern Med. 1951, 34, 20.
50. Beard, C.M.; Benson, R.C.; Kelalis, P.P.; Elveback, L.R.; Kurland, L.T. The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974. Mayo Clin Proc. 1977, 52, 3–7.
51. Shulman, A.; Shohat, B.; Gillis, D.; Yavetz, H.; Homonnai, Z.T.; Paz, G. Mumps orchitis among soldiers: frequency, effect on sperm quality, and sperm antibodies. Fertil Steril. 1992, 57, 1344–1346.
52. Kaufman, J.J.; Bruce, P.T. Testicular atrophy following mumps, a case of testis tumor?. J Urol. 1963, 35, 67–69.
53. Morrison, J.C.; Givens, J.R.; Wiser, W.L.; Fish, S.A. Mumps oophoritis: a cause of premature menopause. Fertil Steril. 1975, 26, 655–659.
54. Hammer, S.M.; Connolly, K.J. Viral aseptic meningitis in the United States: clinical features, viral etiologies, and differential diagnosis. Curr Clin Top Infect Dis. 1992, 12, 1–25.
55. Immunization Practices Advisory Committee. Mumps prevention. MMWR. 1989, 38, 397–400.
56. Russell, R.R.; Donald, J.C. The neurological complications of mumps. Br Med J. 1958, 2, 27–35.
57. Brown, J.W.; Kirkland, H.B.; Hein, G.E. Central nervous system involvement during mumps. Am J Med Sci. 1948, 215, 434–441.
58. Finkelstein, H. Meningo-encephalitis in mumps. JAMA. 1938, 3, 17–19.
59. Wolontis, S.; Bjorvatin, B. Mumps meningoencephalitis in Stockholm November 1964–July 1971. II. Isolation attempts from the cerebrospinal fluid in a hospitalized study group. Scand J Infect Dis. 1973, 5, 261–271.
60. Kilham, L. Mumps meningoencephalitis with and without parotitis. Am J Dis Child. 1949, 78, 324–333.
61. Bruyn, H.B.; Sexton, H.M.; Brainerd, H.D. Mumps meningoencephalitis. A clinical review of 119 cases with one death. Calif Med. 1957, 86, 153–160.
62. Koyama, S.; Morita, K.; Yamaguchi, S.; Fujikane, T.; Sasaki, N.; Aizawa, H.; Kikuchi, K. An adult case of mumps brain stem encephalitis. Intern Med. 2000, 39, 499–502.
63. Wilfert, C.M. Mumps meningoencephalitis with low cerebrospinal-fluid glucose, prolonged pleocytosis and elevation of protein. N Engl J Med. 1969, 280, 855–859.
64. Johnstone, J.A.; Ross, C.A.C.; Dunn, M. Meningitis and encephalitis associated with mumps infection. Arch Dis Child. 1972, 47, 647–651.
65. Vandvik, B.; Nilsen, R.E.; Vartdal, F.; Norrby, E. Mumps meningitis: specific and nonspecific antibody responses in the central nervous system. Acta Neurol Scand. 1982, 65, 468–487.
66. Vandvik, B.; Norrby, E.; Steen-Johnson, J.; Stensvold, K. Mumps meningitis: prolonged pleocytosis and occurrence of mumps virus-specific oligoclonal IgG in the cerebrospinal fluid. Eur Neurol. 1978, 17, 13–22.
67. Link, H.; Laurenzi, M.A.; Fryden, A. Viral antibodies in oligoclonal and polyclonal IgG synthesized within the central nervous system over the course of mumps meningitis. J Neuroimmunol. 1981, 1, 287–298.
68. Fryden, A.; Link, H.; Moller, E. Demonstration of CSF lymphocytes sensitized against mumps virus antigens in mumps meningitis. Acta Neurol Scand. 1978, 57, 396–404.
69. Julkunen, I.; Lehtokoski-Lehtiniemi, E.; Koskiniemi, M.; Vaheri, A. Elevated mumps antibody titers in the cerebrospinal fluid suggesting chronic mumps virus infection in the central nervous system. Pediatr Infect Dis. 1985, 4, 99.
70. Timmons, G.D.; Johnson, K.P. Aqueductal stenosis and hydrocephalus after mumps encephalitis. N Engl J Med. 1970, 283, 1505–1507.
71. Ritter, B.S. Mumps meningoencephalitis in children. J Pediatr. 1958, 52, 424–433.
72. Morishima, T.; Miyazu, M.; Ozaki, T.; Isomura, S.; Suzuki, S. Local immunity in mumps meningitis. Am J Dis Child. 1980, 134, 1060–1064.
73. Taylor, F.B.; Toreson, W.E. Primary mumps meningoencephalitis. Arch Intern Med. 1963, 112, 114–119.
74. Baum, S.G.; Litman, N. Mumps virus. In Principles and Practice of Infectious Diseases; Mandell, G.L.; Churchill Livingstone: Philadelphia, 2000, 1776–1781.
75. Nussinovitch, M.; Volovitz, B.; Varasano, I. Complications of mumps requiring hospitalization in children. Eur J Pediatr. 1995, 154, 732–734.
76. Miller, H.G.; Stanton, J.B.; Gibbons, J.L. Para-infectious encephalomyelitis and related syndromes. A critical review of the neurological complications of certain specific fevers. Quart J Med. 1956, 25, 427–505.
77. Leonberg, S.C. Nervous system affections caused by the mumps virus. Neurol Neurocir Psiquiatr. 1977, 18, 485–493.
78. Modlin, J.F.; Orenstein, W.A.; Brandling-Bennett, A.D. Current status of mumps in the United States. J Infect Dis. 1975, 132, 106–109.
79. Cohen, H.A.; Ashkenazi, A.; Nussinovitch, M.; Amir, J.; Hart, J.; Frydman, M. Mumpsassociated acute cerebellar ataxia. Am J Dis Child. 1992, 146, 930–931.
80. Nussinovitch, M.; Brand, N.; Frydman, M.; Varsano, I. Transverse myelitis following mumps in children. Acta Paediatr. 1992, 81, 183–184.
81. Venketasubramanian, N. Transverse myelitis following mumps in an adult—a case report with MRI correlation. Acta Neurol Scand. 1997, 96, 328–330.
82. Ghosh, S. Guillain-Barre syndrome complicating mumps. Lancet. 1967, 1, 895.
83. Lennette, E.H.; Caplan, G.E.; Magoffin, R.L. Mumps virus infection simulating paralytic poliomyelitis. A report of 11 cases. Paediatrics. 1960, 25, 788–797.
84. Kilham, L.; Levens, J.; Enders, J.F. Nonparalytic poliomyelitis and mumpsmeningoencephalitis. Differential diagnosis. JAMA. 1949, 140, 934–936.
85. Ogata, H.; Oka, K.; Mitsudome, A. Hydrocephalus due to acute aqueductal stenosis following mumps infection: report of a case and review of the literature. Brain Dev. 1992, 14, 417–419.
86. McKenna, M. Measles, mumps, and sensorineural hearing loss. Ann NY Acad Sci. 1997, 830, 291–298.
87. Hall, R.; Richards, H. Hearing loss due to mumps. Arch Dis Child. 1987, 62, 189–191.
88. Smith, G.A.; Guessen, R. Inner ear pathologic features following mumps infection. Arch Otolaryngol. 1976, 102, 108–111.
89. Westmore, G.A.; Pickard, B.H.; Stern, H. Isolation of mumps virus from the inner ear after sudden deafness. Br Med J. 1979, 1, 14–15.
90. Siegel, M.; Fuerst, H.T. Low birth weight and maternal virus diseases. A prospective study of rubella, measles, mumps, chickenpox, and hepatitis. JAMA. 1966, 197, 680–684.
91. Chiba, Y.; Tsutsumi, H.; Nakao, T.; Wakisaka, A.; Aizawa, M. Human leukocyte antigenlinked genetic controls for T-cell mediated cytotoxicity response to mumps virus in humans. Infect Immun. 1982, 35, 600–604.
92. Utz, J.P.; Kasel, J.A.; Cramblett, H.G.; Szwed, C.F.; Parrott, R.H. Clinical and laboratory studies of mumps. I. Laboratory diagnosis by tissue-culture techniques. N Engl J Med. 1957, 257, 497–502.
93. McLean, D.M.; Bach, R.D.; Larke, R.P.; McNaughton, G.A. Mumps meningoencephalitis Toronto, 1963. Can Med Assoc J. 1964, 90, 458–462.
94. Overman, J.R. Viremia in human mumps virus infections. Arch Intern Med. 1958, 102, 354–356.
95. Kilham, L. Isolation of mumps virus from the blood of a patient. Proc Soc Exp Biol Med. 1948, 69, 99–100.
96. Bjorvatn, B.; Wolontis, S. Mumps meningoencephalitis in Stockholm November 1964–July 1971. I. Analysis of a hospitalized study group. Questions of selection and representativity. Scand J Infect Dis. 1973, 5, 253–260.
97. Poggio, G.P.; Rodriguez, C.; Cisterna, D.; Freire, M.C.; Cello, J. Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases. J Clin Microbiol. 2000, 38, 274–278.
98. Cusi, M.G.; Bianchi, S.; Valassina, M.; Santini, L.; Arnetoli, M.; Valensin, P.E. Rapid detection and typing of circulating mumps virus by reverse transcription/polymerase chain reaction. Res Virol. 1996, 147, 227–232.
99. Gellis, S.S.; McGuiness, A.C.; Peters, M. A study of the prevention of mumps orchitis by gammaglobulin. Am J Med Sci. 1945, 210, 661–664.
100. Reed, D.; Brown, G.; Merrick, R.; Sever, J.; Feltz, E. A mumps epidemic on St. George Island, Alaska. JAMA. 1967, 199, 113–117.
101. Buynak, E.B.; Hilleman, M.R. Live attenuated mumps virus vaccine. 1. Vaccine development. Proc Soc Exp Biol Med. 1966, 123, 768–775.
102. German, D.; Ströhle, A.; Eggenberger, K.; Steiner, C.E.; Matter, L. An outbreak of mumps in a population partially vaccinated with the Rubini strain. Scand J Infect Dis. 1996, 28, 235–238.
103. Toscani, L.; Batou, M.; Bouvier, P.; Schlaepfer, A. Comparison of the efficacy of various strains of mumps vaccine: a school survey. Soz Praventivmed. 1996, 41, 341–347.
104. Strohle, A.; Eggenberger, K.; Steiner, C.A.; Matter, L.; Germann, D. Mumps epidemic in vaccinated children in West Switzerland. Schweiz Med Wochenschr. 1997, 127, 1124–1133.
105. Hilleman, M.R. Past, present, and future of measles, mumps, and rubella virus vaccines. Pediatrics. 1992, 90, 149–153.
106. Balraj, V.; Miller, E. Complications of mumps vaccines. Rev Med Virol. 1995, 5, 219–227.
107. Colville, A.; Pugh, M. Mumps meningitis and measles, mumps and rubella vaccine. Lancet. 1992, 340, 786.
108. Miller, E.; Goldacre, M.; Pugh, S.; Colville, A.; Farrington, P.; Flower, A.; Nash, J.; MacFarlane, L.; Tettmar, R. Risk of aseptic meningitis after measles mumps and rubella vaccine in UK children. Lancet. 1993, 341, 979–982.
109. Hyatt, H.W. Complications of mumps. GP. 1962, 25, 124–126.